Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Edwin Charles Pratt

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6054-6983; OpenAlex author ID A5058410474; NIH RePORTER profile ID 14649831. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
3
Labs led
1
Collaborators
3
Papers, trials and grants by year

2023: 1 grant · 2024: 1 paper · 2025: 1 grant · 2026: 1 paper, 1 grant

Papers 2

  1. Trop-2.2-Directed Radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a Pancreatic Cancer Model. Co-author DOI 10.1158/1078-0432.ccr-25-2184↗
  2. uPAR Immuno-PET in Pancreatic Cancer, Aging, and Chemotherapy-Induced Senescence. Co-author DOI 10.2967/jnumed.124.268278↗

Grants 3

  1. Targeting Pancreatic Cancer Senescence with ImmunoPET R00CA276804↗
  2. Targeting Pancreatic Cancer Senescence with ImmunoPET K99CA276804↗
  3. Understanding tumorigenesis and metastasis of pancreatic cancer through precision whole-body imaging of senescence with ImmunoPET F32CA268912↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jason Stuart Lewis · 2 shared papers, 2024–2026 · strength 0.47
  2. David Bauer · 1 shared paper, 2026 · strength 0.26
  3. Scott W. Lowe · 1 shared paper, 2024 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.